Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Esco Technologies | ESE | Sep 27, 2024 | 128.40 | +1.61 |
ESGL | ESGL | Sep 27, 2024 | 2.20 | +4.85 |
ESH Acquisition | ESHA | Sep 27, 2024 | 10.63 | +0.19 |
Eshallgo | EHGO | Sep 27, 2024 | 1.98 | 0.00 |
Esperion Therapeutics | ESPR | Sep 27, 2024 | 1.68 | +2.44 |
Espey Mfg & Electronics | ESP | Sep 27, 2024 | 24.81 | +2.33 |
Esquire Financial | ESQ | Sep 27, 2024 | 64.38 | +1.82 |
ESS Tech | GWH | Sep 27, 2024 | 6.62 | +1.53 |
ESSA Bancorp | ESSA | Sep 27, 2024 | 19.42 | +1.36 |
ESSA Pharma | EPIX | Sep 27, 2024 | 6.44 | +3.70 |
Essent Group | ESNT | Sep 27, 2024 | 63.87 | +0.82 |
Essential Properties Realty Trust | EPRT | Sep 27, 2024 | 34.15 | +0.50 |
Essential Utilities | WTRG | Sep 27, 2024 | 38.40 | +0.76 |
Essex Property Trust | ESS | Sep 27, 2024 | 294.60 | +0.15 |
Establishment Labs | ESTA | Sep 27, 2024 | 47.04 | +14.19 |
Estee Lauder Companies | EL | Sep 27, 2024 | 99.87 | -0.90 |
Estrella Immunopharma | ESLA | Sep 27, 2024 | 1.19 | +22.69 |
Eterna Therapeutics | ERNA | Sep 27, 2024 | 1.15 | -9.45 |
ETFMG Alternative Harvest ETF | MJ | Sep 27, 2024 | 3.29 | -1.79 |
Ethan Allen Interiors | ETD | Sep 27, 2024 | 31.78 | +1.21 |
Eton Pharmaceuticals | ETON | Sep 27, 2024 | 5.80 | +2.11 |
Etsy | ETSY | Sep 27, 2024 | 57.14 | +2.49 |
Euda Health | EUDA | Sep 27, 2024 | 4.00 | -1.48 |
Eupraxia Pharmaceuticals | EPRX | Sep 27, 2024 | 2.63 | 0.00 |
Eureka Acquisition | EURK | Sep 27, 2024 | 10.04 | 0.00 |
Eureka Acquisition | EURKU | Sep 27, 2024 | 10.22 | 0.00 |
Euro Tech Holdings | CLWT | Sep 27, 2024 | 1.64 | +0.61 |
Euro Trust | FXE | Sep 27, 2024 | 103.15 | -0.12 |
EuroDry | EDRY | Sep 27, 2024 | 20.61 | -0.57 |
Euronav | EURN | Sep 27, 2024 | 16.31 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.